Itau Unibanco Holding S.A.’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,373	Closed	-$2.65M	–	1010
2019 Q3	$2.65M	Hold	50,373	–	–	0.14%	61
2019 Q2	$2.65M	Buy	50,373 +49,721	+7,626%	+$2.86M	0.13%	56
2019 Q1	$26K	Hold	652	–	–	﹤0.01%	556
2018 Q4	$26K	Buy	652 +67	+11%	+$2.51K	﹤0.01%	556
2018 Q3	$22K	Sell	585 -219	-27%	-$9.7K	﹤0.01%	568
2018 Q2	$36K	Sell	804 -5	-0.6%	-$228	﹤0.01%	639
2018 Q1	$39K	Buy	+809	New	+$45.1K	﹤0.01%	496

Other funds holding GBT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Itau Unibanco Holding S.A.'s GBT Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2019, closing a stake of 50,373 shares — an estimated $2.65M sold.

Itau Unibanco Holding S.A. first reported a position in GBT in Q1 2018 and held it in 7 quarters. The position peaked at $2.65M in Q3 2019. 234 funds tracked by Wall St. Rank hold GBT as of Q4 2019.

Itau Unibanco Holding S.A. reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 50,373 Global Blood Therapeutics, Inc. shares in Q4 2019, an estimated $2.65M.
Itau Unibanco Holding S.A. first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 7 quarters.
Itau Unibanco Holding S.A.'s Global Blood Therapeutics, Inc. position peaked at $2.65M in Q3 2019.
234 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.